Understanding Pancreatic Cancer: Types, Stages, Treatment & Integrative Care
Updated: Nov 4

Pancreatic cancer is one of the more challenging cancers to diagnose and treat, largely because it often develops without noticeable symptoms during its earliest stages. By the time symptoms appear, the disease may have already progressed beyond the pancreas, making early detection and treatment particularly difficult. However, advances in diagnostic imaging, molecular testing, conventional cancer treatments, and integrative oncology are creating new opportunities to improve care for those affected by this disease.
Pancreatic cancer, like all cancers, is a multifaceted disease. Its development and progression involve a complex interaction of genetic mutations, chronic inflammation, metabolic dysfunction, immune system activity, environmental exposures, and other biological factors. While conventional oncology focuses primarily on treating the cancer itself, integrative oncology takes a broader approach by considering the many factors that influence a person's overall health and ability to respond to treatment.
In this article, I’ll share risk factors associated with pancreatic cancer, how it's diagnosed and treated, and the role of integrative oncology can play in providing comprehensive and individualized care.
Understanding the Pancreas and Pancreatic Cancer
The pancreas is an elongated organ located behind the stomach that has two essential roles in the body. First, its exocrine function involves producing digestive enzymes that help break down proteins, fats, and carbohydrates. Second, its endocrine function produces insulin and glucagon, which regulate blood sugar levels. When the pancreas isn't functioning properly, one may experience digestive disturbances, difficulty absorbing nutrients, unintended weight loss, and changes in blood glucose regulation.
Pancreatic cancer develops when abnormal cells within the pancreas begin to grow uncontrollably, eventually forming a malignant tumor. Approximately 90% of pancreatic cancers are pancreatic ductal adenocarcinomas (PDAC), which arise from the cells lining the pancreatic ducts. Less common forms include pancreatic neuroendocrine tumors, which originate from hormone producing cells and may behave quite differently from pancreatic adenocarcinoma.
Who Develops Pancreatic Cancer?
Pancreatic cancer occurs most frequently in older adults, with the majority of cases diagnosed after age 60. Men have a slightly higher incidence than women, and in the United States, Black Americans experience higher rates of pancreatic cancer than several other racial and ethnic groups. Although pancreatic cancer is more common later in life, it can also develop in younger adults, particularly those with inherited genetic mutations or a strong family history.
There's no single cause of pancreatic cancer. Instead, the disease develops through a combination of genetic alterations and changes in the cellular environment that allow abnormal cells to survive, multiply, and eventually become malignant. Several established risk factors have been associated with an increased likelihood of developing pancreatic cancer.
These include:
• Smoking and tobacco exposure
• Obesity, insulin resistance, and type 2 diabetes
• Chronic pancreatitis
• Family history of pancreatic cancer
• Inherited genetic mutations, including BRCA1, BRCA2, PALB2, and ATM
• Certain dietary patterns and environmental exposures
Genetics plays an especially important role in pancreatic cancer. Mutations in the KRAS gene are found in the vast majority of pancreatic ductal adenocarcinomas and can promote abnormal cellular growth. Other commonly altered genes include TP53, CDKN2A, and SMAD4, which normally help regulate cell division and tumor suppression. However, most pancreatic cancers aren't directly inherited, even though genetic changes are central to the development of the disease.
Chronic Inflammation, Metabolic Health, and the Microbiome
One of the more interesting areas of pancreatic cancer research involves the biological environment in which the disease develops. Chronic inflammation, insulin resistance, elevated blood glucose, and changes in cellular metabolism can influence pathways associated with cancer development and progression. These relationships are particularly relevant in pancreatic cancer because the pancreas plays such an important role in digestion and glucose regulation.
The oral and gastrointestinal microbiomes are also receiving increasing attention in cancer research. These complex communities of microorganisms influence digestion, immune regulation, inflammation, and metabolic health. When the balance of these microorganisms becomes disrupted, a condition known as dysbiosis, changes in microbial activity can contribute to an environment that favors chronic inflammation and other processes associated with cancer.
Research has identified associations between pancreatic cancer and certain oral microorganisms, including Porphyromonas gingivalis, a bacterium associated with periodontal disease. Studies have also identified differences in the gastrointestinal microbiomes of individuals with pancreatic cancer compared with those without the disease. Although these findings don't establish that specific microorganisms cause pancreatic cancer, they raise important questions about how microbial health may influence cancer biology and treatment response.
For those interested in exploring these relationships further, I encourage you to read my articles, The Link Between Oral Health and Cancer and How the Microbiome Influences the Development and Progression of Cancer.
Signs, Symptoms, and Diagnosis
One of the greatest challenges associated with pancreatic cancer is that symptoms often don't appear until the disease has progressed. Even when symptoms develop, they can be relatively nonspecific and may initially be attributed to more common gastrointestinal conditions. The location of the tumor within the pancreas can also influence which symptoms develop and how early they become noticeable.
Common signs and symptoms include:
• Unexplained weight loss and loss of appetite
• Abdominal discomfort that may radiate into the back
• Nausea, bloating, and changes in bowel habits
• Fatigue and weakness
• Jaundice, which may cause yellowing of the skin and eyes
• Pale or greasy stools and dark urine
• Newly diagnosed diabetes or unexplained changes in blood glucose
Diagnosing pancreatic cancer generally involves imaging studies such as CT scans, MRI, and endoscopic ultrasound. A biopsy may be performed to confirm the diagnosis, while blood tests, including the tumor marker CA 19-9, can provide additional information. CA 19-9 is often useful for monitoring treatment response, however, on its own, it doesn’t conclusively diagnosis pancreatic cancer.
Staging Pancreatic Cancer
Once pancreatic cancer has been diagnosed, determining the extent of the disease is essential for developing an appropriate treatment plan. Although pancreatic cancer can be classified using the traditional TNM staging system, physicians also categorize tumors according to whether they can be surgically removed.
The primary categories include:
Resectable: The tumor appears confined to an area where complete surgical removal is possible.
Borderline resectable: The tumor involves or approaches important blood vessels, making surgery more complicated.
Locally advanced: The tumor has extended into nearby structures or blood vessels and generally can't be removed surgically at diagnosis.
Metastatic: Cancer cells have spread to distant organs, most commonly the liver, lungs, or abdominal lining.
Treatment decisions depend on the stage of the cancer, the tumor's molecular characteristics, the patient's overall health, and his/her individual goals of care.
Conventional Treatment for Pancreatic Cancer
Conventional treatment for pancreatic cancer typically involves surgery, chemotherapy, radiation therapy, and, in selected cases, targeted therapies. The most appropriate approach depends on the stage of the disease and whether the tumor can be surgically removed.
Surgery
Surgery offers the primary opportunity for long-term disease control in patients with localized, operable pancreatic cancer. Tumors located in the head of the pancreas may be treated with a Whipple procedure, which involves removing the head of the pancreas, the duodenum, gallbladder, and portions of the bile duct. Tumors located in the body or tail of the pancreas may be treated with a distal pancreatectomy, sometimes accompanied by removal of the spleen.
Because pancreatic surgery can significantly affect digestion and blood glucose regulation, nutritional management and digestive support are particularly important during recovery.
Chemotherapy and Radiation Therapy
Chemotherapy is commonly used before or after surgery and is the primary treatment for many patients with locally advanced or metastatic pancreatic cancer. Common regimens include modified FOLFIRINOX, gemcitabine combined with nab-paclitaxel, and NALIRIFOX. These treatments can slow disease progression and extend survival, but they may also cause fatigue, nausea, diarrhea, peripheral neuropathy, decreased blood counts, and nutritional challenges.
Radiation therapy may be recommended in selected cases to improve local tumor control, manage symptoms, or potentially facilitate surgery. Stereotactic radiation therapy, provides focused radiation treatment, while limiting exposure to surrounding healthy tissue.
Targeted Therapy and Molecular Testing
Molecular testing is becoming increasingly popular and important in pancreatic cancer care. Certain inherited genetic alterations may help identify patients who could benefit from targeted treatments or clinical trials. For example, individuals with BRCA related mutations may respond well to platinum-based chemotherapy, while selected patients may benefit from PARP inhibitors.
Comprehensive molecular profiling can identify additional treatment options that wouldn't necessarily be apparent from conventional imaging or pathology alone. This is another example of how personalized cancer care continues to evolve.
Integrative Oncology Care for Pancreatic Cancer
Integrative oncology brings together the strengths of conventional Western medicine and natural medicine to create a more comprehensive approach to cancer care. Rather than choosing one system of medicine over another, the goal is to thoughtfully integrate both, recognizing that cancer affects far more than the organ in which it develops.
For individuals with pancreatic cancer, this approach is particularly relevant because the disease frequently affects digestion, nutrient absorption, metabolism, and overall nutritional status. Integrative care may incorporate personalized nutrition, oncology acupuncture, botanical medicine, digestive support, and other therapeutic strategies that address the patient's individual needs.
Personalized Nutrition and Digestive Support
Nutrition is one of the most important considerations in pancreatic cancer care. Because the pancreas produces enzymes necessary for digestion, pancreatic tumors and surgical procedures can interfere with the body's ability to properly break down and absorb nutrients. This may result in pancreatic exocrine insufficiency, a condition that can cause bloating, diarrhea, greasy stools, malabsorption, and unintended weight loss.
Patients with pancreatic exocrine insufficiency often benefit from pancreatic enzyme replacement therapy, which helps improve digestion and nutrient absorption. Adequate protein intake, smaller and more frequent meals, healthy fats, and individualized nutritional support can also help maintain strength and body weight during treatment.
Although I usually recommend a predominantly plant-based, anti-inflammatory diet for those affected by cancer, the immediate nutritional priorities for someone with pancreatic cancer, may need to be modified. Dietary recommendations should consider preserving muscle mass, preventing further weight loss, and maintaining adequate calorie and protein intake.
Oral and Gastrointestinal Microbiome Assessment
From an integrative oncology perspective, the oral and gastrointestinal microbiomes represent another important area of health worth exploring. Comprehensive gastrointestinal testing can provide information about microbial populations, digestive function, intestinal inflammation, and other markers that may help explain persistent gastrointestinal symptoms. Oral microbiome testing offers additional insight into the microorganisms associated with oral and periodontal health.
For individuals with pancreatic cancer, digestive symptoms may arise from several causes, including pancreatic enzyme insufficiency, changes in bile flow, chemotherapy, medications, and alterations in the intestinal microbiome. Understanding these different contributors can help guide a more individualized approach to nutritional and gastrointestinal support.
Although microbiome testing isn't currently used to diagnose pancreatic cancer or determine which cancer treatments will be effective, it may provide additional information about digestive and microbial health when interpreted within the context of the patient's symptoms and medical history. In my clinical approach, the purpose of advanced testing is to better understand the individual and identify areas where targeted support may be appropriate.
To learn more, explore my articles Cancer and the Critical Role of Gut Health Assessment and The Importance of Oral Microbiome Health During and After Cancer Treatment.
Oncology Acupuncture
Acupuncture is one of the oldest healing practices in the world and is probably the best known modality of Traditional Chinese Medicine. Oncology acupuncture is a specialized field of acupuncture that focuses on providing appropriate and individualized acupuncture care to those undergoing treatment for cancer.
Research supports acupuncture for several cancer related symptoms and treatment side effects, including nausea and vomiting, fatigue, insomnia, anxiety, pain, hot flashes, night sweats, and peripheral neuropathy, although the strength of evidence varies by symptom. For individuals with pancreatic cancer, acupuncture may be particularly valuable for managing nausea, treatment related neuropathy, discomfort, and overall quality of life.
To learn more about oncology acupuncture and its role in integrative cancer care, read Oncology Acupuncture: Understanding Its Role in Cancer Care.
Botanical Medicine and Emerging Therapies
Botanical medicine and targeted nutritional supplementation may also play a role in individualized integrative oncology care. Certain natural compounds, including curcumin and medicinal mushroom extracts, have demonstrated anti-inflammatory, immunomodulatory, or anticancer activity in laboratory and preclinical research. While clinical evidence continues to evolve, these findings have generated considerable interest in how naturally derived compounds may influence cancer related biology.
Another area of emerging research involves high dose intravenous vitamin C, also known as pharmacological ascorbate. Unlike oral vitamin C, intravenous administration can achieve substantially higher concentrations in the bloodstream, producing biological effects that researchers are investigating for their potential role in cancer treatment. Recent clinical trials in pancreatic cancer have reported encouraging findings, including improvements in survival when intravenous vitamin C was combined with certain chemotherapy regimens.
In my next article, High Dose Intravenous Vitamin C and Pancreatic Cancer, I'll share how pharmacological vitamin C works, and why it's generating interest in integrative oncology.
A Broader Approach to Pancreatic Cancer Care
Pancreatic cancer is a complex disease that affects much more than the pancreas itself. Its development and progression involve genetic, metabolic, inflammatory, and immune related processes, while its treatments can significantly influence digestion, nutrition, and overall health. Understanding these interconnected factors creates opportunities for a more comprehensive and individualized approach to care.
Conventional oncology provides essential treatments directed at controlling or eliminating cancer, while integrative oncology expands care to include nutritional health, metabolic function, digestive support, symptom management, and emerging therapeutic strategies. By bringing these approaches together, patients have an opportunity to explore additional ways to support their health throughout treatment and beyond.
To learn more about integrative approaches to cancer care, explore the educational resources available here at Integrative Oncology Specialist.




